Related Experiment Video
Updated: Jul 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Causes and consequences of increased arterial stiffness in chronic kidney disease patients
Paul Gusbeth-Tatomir1, Adrian Covic
1Dialysis and Renal Transplantation Center, Parhon University Hospital, Iasi, Romania.
Insights
Patients with chronic kidney disease face higher cardiovascular risks due to arterial stiffness, a sign of premature vascular aging. Understanding its causes and consequences is key to developing better treatments.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease is a leading cause of death in patients with chronic kidney disease (CKD).
- Arterial stiffness, indicative of premature vascular aging, is a significant contributor to cardiovascular complications in CKD.
- Factors like vascular calcification, inflammation, and endothelial dysfunction exacerbate arterial stiffness in renal patients.
Purpose of the Study:
- To review the pathophysiological mechanisms underlying reduced arterial compliance in CKD.
- To discuss the clinical consequences of increased arterial stiffness in CKD patients.
- To explore potential therapeutic strategies for mitigating cardiovascular burden in CKD.
Main Methods:
- Literature review of pathophysiological mechanisms of arterial stiffness in CKD.
- Analysis of clinical consequences associated with arterial stiffness.
- Discussion of current and potential therapeutic interventions.
Main Results:
- Arterial stiffness is a key factor in the elevated cardiovascular morbidity and mortality observed in CKD patients.
- Pathophysiological mechanisms include vascular calcification, chronic volume overload, inflammation, endothelial dysfunction, and oxidative stress.
- Clinical consequences encompass isolated systolic hypertension, left ventricular hypertrophy, and reduced myocardial perfusion.
Conclusions:
- Increased arterial stiffness is a critical determinant of cardiovascular risk in chronic kidney disease.
- A deeper understanding of arterial stiffening mechanisms can guide the development of targeted therapies.
- Therapeutic strategies may involve specific antihypertensive drugs and interventions to reduce vascular calcification.
Abstract:
Cardiovascular (CV) morbidity and mortality is greatly enhanced in patients with chronic kidney disease, compared to the non-renal population. One key element of this high CV burden appears to be arterial stiffness, as an expression of premature vascular aging. Increased arterial stiffness in renal patients may be a consequence of vascular calcification, chronic volume overload, inflammation, endothelial dysfunction, oxidative stress and several other factors. The authors review briefly the main pathophysiological mechanisms leading to reduced arterial compliance. Increased arterial stiffness has significant clinical consequences: isolated systolic hypertension, left ventricular hypertrophy (and failure), and reduced myocardial perfusion. Better knowledge of the mechanisms of arterial functional and morphologic alteration may help in developing more refined therapeutic strategies aimed to reduce the high CV burden in chronic kidney disease. The potential therapeutic interventions - mainly the use of certain antihypertensive drugs and reduction of vascular calcification - are finally discussed.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Diabetic Nephropathy

